Latest multiple sclerosis News | Page 3

First Aus-NZ clinical guidance developed for people living with multiple sclerosis
Long COVID: women at greater risk compared to men – could immune system differences be the cause?
All in the eyes: High resolution retinal maps aid disease diagnoses
Beyond depression: surprising health conditions antidepressants can treat
What’s the difference between Hass and Shepard avocados? It’s not just the colour
Red light therapy shows promise for pain relief, inflammation and skin conditions – but other claims might be hyped
What is PNF stretching, and will it improve my flexibility?
Moment in the sun: why greenspace planning is key to better health
How chronic illness affects families – and how to cope when you know your loved one is going to die
MS brain atlas could pave the way for personalised treatment
Monash Receives $49m In NHMRC Ideas Grants
Vaccine misinformation distorts science – a biochemist explains how RFK Jr. and his lawyer’s claims threaten public health
Prestigious National Health and Medical Research Council grants worth $3.74 million awarded to four QIMR Berghofer scientists
Sex differences in neuron protection could reveal Alzheimer’s target
Neuro Researchers Receive KID Grants
Yes, you still need to use sunscreen, despite what you’ve heard on TikTok
Lifestyle changes can boost brain health and slow decline for people living with MS
Novel Selenium Carrier Protein Regulates Ferroptosis in Cancer and Brain
Research grants from the Swedish Research Council to CNS researchers
Disclose invisible disabilities in social VR? It depends
Glioblastoma: why immunotherapy may offer hope for brain cancer patients
Encephalitis lethargica: the mysterious disease that inspired Awakenings is finally starting to give up some clues
Playing in mud and dirt can boost your child’s immune system – here’s how
Is Cannabis Answer To Insomnia?
Ignored, blamed, and sometimes left to die – a leading expert in ME explains the origins of a modern medical ‘scandal’
DEA could reclassify marijuana to a less restrictive category – a drug policy expert weighs the pros and cons
Gene-edited Cells Could Halt MS Progression
Eastern Health Clinician leading international autoimmune research
PBS Changes From 1 October
It’s Time To Op Shop Till You Drop
Merck Unveils New MAVENCLAD® Four-Year Data Highlighting Benefits of Early Treatment and Sustained Efficacy Across Multiple Measures of Disease Activity
Nutrition program for people with MS shows promising results
Patients welcome better access to Shingrix® for immunocompromised patients
Thinking of trying a new diet? 4 questions to ask yourself before you do
The indoor microbiome: mounting research is revealing how the microbes in your home can influence your health
Percheron Therapeutics announces positive preclinical data for avicursen
“Make multiple sclerosis a disease without disability”: vision of $3m Centre of Research Excellence at Menzies
Merck Announces First Patient Dosed in Phase III Study of Oral Cladribine in Generalized Myasthenia Gravis (gMG)
Grant Recipients Share In Over $285,000
Vaccines tell a success story that Robert F. Kennedy Jr. and Trump forget – here are some key reminders
Fujirebio Launches the Fully Automated Lumipulse® G GFAP Assay for Research Use Only and Further Strengthens its Neuro Test Menu
What’s the difference between ‘strep throat’ and a sore throat? We’re developing a vaccine for one of them
Merz Therapeutics Closes $185M Asset Purchase Agreement with Acorda Therapeutics
Commercialising A.I. To Unlock Mystery Of Multiple Sclerosis
“Profound impact,” legacy of a $10m multiple sclerosis funding boost
Professor Peter van Wijngaarden to become next Director and CEO of The Florey
$57 million for research to transform health care using the power of AI and to fight genetic disease
Unlocking Power Of AI To Transform Healthcare